Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Eimeria tenella | cGMP-dependent protein kinase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0469 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0923 | 0.0476 |
Echinococcus multilocularis | expressed conserved protein | 0.006 | 0.2283 | 0.1903 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0028 | 0.0876 | 0.0427 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0923 | 0.1009 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0214 | 0.9081 | 0.9036 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0469 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0029 | 0.0923 | 0.0476 |
Schistosoma mansoni | serine/threonine protein kinase | 0.006 | 0.2283 | 0.2507 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0029 | 0.0923 | 0.2504 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0214 | 0.9081 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0923 | 0.1009 |
Plasmodium vivax | SET domain protein, putative | 0.0029 | 0.0923 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.006 | 0.2283 | 0.2507 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0214 | 0.9081 | 0.9036 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0469 | 0.5 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0214 | 0.9081 | 0.9207 |
Echinococcus granulosus | cGMP dependent protein kinase | 0.006 | 0.2283 | 0.1903 |
Echinococcus granulosus | cGMP dependent protein kinase 1 | 0.006 | 0.2283 | 0.1903 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0923 | 0.1009 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2357 | 0.2589 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0469 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0469 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2357 | 0.2589 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.2357 | 0.1981 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.2357 | 0.1981 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | 0.0214 | 0.9081 | 0.9036 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0029 | 0.0923 | 0.0476 |
Onchocerca volvulus | 0.0048 | 0.1758 | 0.0942 | |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0469 | 0.0509 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0048 | 0.1758 | 0.1352 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.2357 | 0.1981 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.2357 | 0.1981 |
Echinococcus multilocularis | cGMP dependent protein kinase 1 | 0.006 | 0.2283 | 0.1903 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2357 | 0.2589 |
Brugia malayi | Pre-SET motif family protein | 0.0202 | 0.8553 | 0.8482 |
Mycobacterium ulcerans | hypothetical protein | 0.0059 | 0.2266 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0029 | 0.0923 | 0.0476 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.2357 | 0.1981 |
Plasmodium falciparum | cGMP-dependent protein kinase | 0.006 | 0.2283 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0048 | 0.1758 | 0.1929 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0469 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.2357 | 0.1981 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0469 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0469 | 1 |
Brugia malayi | RNA binding protein | 0.0062 | 0.2357 | 0.1981 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 1 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0235 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0469 | 0.0509 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2357 | 0.2589 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1758 | 0.1929 |
Brugia malayi | Pre-SET motif family protein | 0.0029 | 0.0923 | 0.0476 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0202 | 0.8553 | 0.8482 |
Loa Loa (eye worm) | AGC/PKG protein kinase | 0.006 | 0.2283 | 0.1903 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0469 | 0.207 |
Onchocerca volvulus | 0.023 | 0.9784 | 1 | |
Brugia malayi | Egg laying defective protein 4 | 0.006 | 0.2283 | 0.1903 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0469 | 0.5 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0214 | 0.9081 | 0.9036 |
Toxoplasma gondii | protein kinase G AGC kinase family member PKG | 0.006 | 0.2283 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0029 | 0.0923 | 0.1009 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2357 | 0.2589 |
Echinococcus multilocularis | cGMP dependent protein kinase 1 | 0.006 | 0.2283 | 0.1903 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0235 | 1 | 1 |
Echinococcus granulosus | cGMP dependent protein kinase 1 | 0.006 | 0.2283 | 0.1903 |
Trichomonas vaginalis | set domain proteins, putative | 0.023 | 0.9784 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.2357 | 0.1981 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.8 nM | Inhibition of Eimeria tenella parasite-specific cGMP-dependent protein kinase | ChEMBL. | 19195883 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.